Eyenovia Announces FDA Acceptance of IND Application for MicroPine to Reduce the Progression of Myopia
longevity investing Evolus Phase III European – Canadian Head-to-Head Trial of prabotulinumtoxinA Compared to Botox® Meets Primary Endpoint
Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2017 Financial Results
pharmaceutical investing ChemoCentryx Reports Fourth Quarter and Full Year 2017 Financial Results and Recent Highlights
gold investing Newrange Gold Samples Up To 130 Grams Gold, Extends Merritt Zone And Begins Phase III Drilling At Pamlico
pharmaceutical investing Novartis receives FDA approval for Cosentyx label update to include moderate-to-severe scalp psoriasis
Newrange Gold Reports Last Drill Results for 2017 and Start of 2018 Drilling At Pamlico Gold Project, Nevada
Alvopetro Announces Q3 2026 Dividend of US$0.12 Per Share and Supplementary Information on December 31, 2025 Prospective Resources
Skyharbour Partner Company Purecore Commences Data Compilation and Target Generation at The Yurchison Uranium Property
